NeuroScientific Biopharmaceuticals Ltd Sustainability Reports

NeuroScientific Biopharmaceuticals Ltd is an Australia-based biotechnology company engaged in the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases.

Sector: Manufacturing

Country: Australia

Exchange: Australian Securities Exchange

LEI: 254900YGHQSAMJODKC85

FIGI: BBG00KW6L707

7 reports from 2018 to 2025

• NeuroScientific Biopharmaceuticals Ltd 2025 Appendix 4E
• NeuroScientific Biopharmaceuticals Ltd 2024 Appendix 4E Shareholder Information
• NeuroScientific Biopharmaceuticals Ltd 2023 Annual Report
• NeuroScientific Biopharmaceuticals Ltd 2022 Annual Report
• NeuroScientific Biopharmaceuticals Ltd 2021 Appendix 4E Preliminary Final Report